New treatment for cryptococcal meningitis enters Phase II trial but HIV funding cuts threaten advances against HIV disease

A new, easier-to-administer and patient-friendly sustained-release formulation of flucytosine, a medicine used to treat cryptococcal meningitis, has entered Phase II…